Skip to main content

This job has expired

You will need to login before you can apply for a job.

Scientist, Molecular Biology (Bioinformatics)

Employer
Molecular Templates, Inc.
Location
Austin, TX, USA
Start date
Nov 3, 2020

View more

Discipline
Science/R&D, Biotechnology
Required Education
Masters Degree/MBA
Position Type
Full time

Job Details

Company Description:

Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases. For more information, please visit MTEM's website at www.mtem.com

Position Overview:

Molecular Templates is seeking an accomplished and highly-motivated Scientist to join the Molecular Biology group as part of the research and development (R&D) team. This position will be primarily office-based and focused on the design, analysis, and optimization of novel biologics and ETBs using computational biology. The Scientist will contribute to the advancement of platform technology through the development and curation of in silico tools for DNA and protein sequence generation and analysis. The Scientist is expected to work on projects with minimal direct supervision and apply good judgment within defined procedures and practices to define appropriate actions. The Scientist may work with more junior team members to train and mentor them. In addition, they may lead R&D projects to drive the forward progress of pipeline candidates at the discretion of the management team and in line with R&D priorities.

Job Responsibilities will include:
  • Work cross-functionally among R&D teams, workstreams, and programs to improve data management and reporting
  • Implement, curate, and maintain LIMS/ ELN to drive Research and Development activities
  • Serve as R&D database administrator
  • Based on methods utilized across industry, develops in silico tools, in vitro assays and experimental systems for use at MTEM to interrogate ETB biology. This includes assay development and validation, SOP generation and training.
  • Execute and manage projects of defined scope to describe the physical, biochemical, and functional profile of candidate ETBs, as directed by project team leaders
  • Apply new technologies to optimize and develop new screening methods for the evaluation and rapid identification of novel biotherapeutics.
  • Analyzes data and draws logical conclusions to define further action and effectively communicate to team members and management in a timely manner
  • Maintain knowledge of scientific trends, industry processes and pipeline target literature through readings, conferences, and seminars in order to contribute to strategic development of novel ETB platforms.
  • Document all procedures in an accurate and timely manner.
  • Conduct general laboratory duties, including ordering supplies and maintaining inventory and laboratory equipment as needed.
  • May function as a subject matter expert and point of contact for the specific functions/equipment within the department
  • With guidance from management executes and manages new projects, as needed.
  • May interface with various departments and serve as internal consultant, as needed. May interface with external CRO or Vendors to deliver on project goals.
  • Supports in mentoring and training junior team members at the discretion of the management team
  • Other duties and responsibilities may be assigned by supervisor, as needed.

Qualifications:
  • Master's degree with 4+ years of relevant laboratory experience; or PhD in Bioinformatics, Computational Biology, Computer Science, Molecular Biology or related field with 2+ years of relevant laboratory experience.
  • Experience in industry R&D, preferred
  • Experience in DNA and protein in silico construct design and sequence analysis
  • Experience in the development and maintenance of scientific software and databases
  • Demonstrated understanding and application of scientific computing and programming/ scripting languages (e.g. Python or R), relational databases (SQL), and APIs preferred
  • Experience in designing information architecture, naming conventions, mind/ concept mapping, and metadata analyses preferred
  • Excellent written and verbal communication skills
  • Excellent computer skills with knowledge of spreadsheet, word processing and statistical analysis software
  • Excellent problem-solving and analytical skills applied to investigations
  • Excellent project management, time management, and multi-tasking skills
  • Proven ability to design research projects independently and provide thought-leadership
  • Ability to manage competing priorities or projects and meet deadlines
  • Ability to function independently and exercise good judgement, as well as work closely in cross-functional teams to support multiple pre-clinical stage programs
  • Ability to clearly and efficiently document, communicate and present complex data sets
  • Ability to function in a fast-paced, high-growth and team-based work environment


Reporting Structure:

This position may have supervisory responsibilities. This position reports to the Director of Molecular Biology, R&D.

Molecular Templates, Inc. is an Equal Opportunity Employer and offers competitive salaries and benefits.

Molecular Templates Inc https://mtem.isolvedhire.com

Company

Molecular Templates, Inc. (MTEM) is a clinical stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform with unique mechanisms of actions which are highly differentiated from antibody drug conjugates (ADCs). MTEM is developing MT-6402, which is in a Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients; MT-5111, which is in a Phase I clinical trial for the treatment of HER2-positive cancers; and MT-0169, which is in a Phase I clinical trial to treat relapsed/refractory myeloma. Additional preclinical compounds derived from our ETB platform technology are being advanced toward clinical development.  Additional information about MTEM can be obtained at www.mtem.com.  

OWNERSHIP: Public

STOCK SYMBOL: MTEM

STOCK EXCHANGE: NASDAQ

Company info
Website
Phone
512-869-1555
Location
9301 Amberglen Blvd, Ste 100
Austin
TX
78729
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert